CERT vs JNJ · rev $187.4M vs P/E 17, rev $49.37B
Certara Inc (CERT) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Certara Inc (CERT) is a health information services company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported CERT revenue for 2026-06-30 was $187.4M. Net income was -$64.0M. Revenue was up 75.2% from 2026-03-31 to 2026-06-30. CERT currently screens at market cap $1.86B.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
CERT currently screens at market cap $1.86B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the CERT and JNJ stock pages for the full models.
Not investment advice.